GlassScriptPhysician profile
Lisa B Barr
NPI 1487682985
$2,186.33
in general payments reported to CMS, 2019-2025
21 companies · $275 in 2025
The $275 reported for 2025 was less than what a typical Pain Medicine (Physical Medicine & Rehabilitation) provider received nationally (typical 2025 total: $400).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $533 · 2020: $222 · 2021: $171 · 2022: $106 · 2023: $873 · 2024: $6.32 · 2025: $275.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $600 · Food and Beverage: $555.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $599.87 |
| Food and Beverage | $554.63 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pacira Pharmaceuticals Incorporated | $655.47 | 2023 | Iovera |
| Abbott Laboratories | $200.02 | 2019-2025 | Proclaim |
| Electronic Waveform Lab, INC. | $199.53 | 2019-2025 | |
| Medline Industries LP | $151.00 | 2019 | |
| Medtronic, INC. | $141.96 | 2021-2023 | Synchromedii |
| Vertex Pharmaceuticals Incorporated | $120.22 | 2025 | |
| Medical Device Business Services, INC. | $113.78 | 2019 | |
| Fidia Pharma USA INC. | $99.19 | 2019-2022 | |
| Abbvie INC. | $98.51 | 2023 | Botox |
| Bioventus LLC | $91.53 | 2019-2020 | |
| Pacira Therapeutics, INC. | $50.59 | 2019-2020 | |
| Nevro Corp. | $49.29 | 2019 | |
| Scilex Pharmaceuticals INC. | $37.15 | 2019 | |
| Almatica Pharma LLC | $36.34 | 2022 | |
| Allergan, INC. | $27.83 | 2020 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biodelivery Sciences International, INC. | $27.19 | 2020 | |
| Ibsa Pharma INC. | $21.03 | 2022 | |
| Arbor Pharmaceuticals, INC. | $20.23 | 2020 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $17.56 | 2021 | |
| Ferring Pharmaceuticals INC. | $15.61 | 2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $12.30 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lisa Barr listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.